Auricle is developing a neurostimulation implant designed to restore auditory function in individuals with hearing loss. This device targets the auditory nerve, providing a direct electrical stimulation that enhances sound perception and improves communication abilities.

The startup develops a clinical analytics platform that utilizes data science to enhance decision-making throughout a patient's acute care journey, from admission to discharge. By providing actionable insights, the platform aims to improve clinical outcomes and operational efficiency in hospitals.

Geneyx provides DNA and RNA data analysis and interpretation for whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, enabling rapid transformation of raw genetic data into clinical reports. The platform enhances diagnostic accuracy and efficiency, aiming to eliminate undiagnosed diseases by increasing the diagnostic yield and reducing turnaround times for genetic testing.

This startup develops magnetic nanotechnology for radiation-free cancer diagnosis, focusing on applications such as staging, screening, and imaging. By eliminating the need for radioactivity and harsh chemicals, the technology enables healthcare providers to offer precise and less invasive treatment options for cancer patients.

The startup has developed a patient monitoring system that integrates medical hardware with big data analytics to continuously track core vital signs. This system enables clinicians to visualize patient trends, configure alerts, and manage wards, enhancing real-time patient care and safety.

Stasys has developed the Atlas Platelet Strength Test, a microfluidics-based system that measures platelet strength in a native blood sample within three minutes, without the need for external reagents. This technology provides rapid, actionable insights into bleeding risk and transfusion needs, enabling clinicians to make informed decisions during critical care situations.

The startup has developed a handheld device that utilizes non-invasive imaging technology to assess the malignancy of skin growths, providing objective evaluations by non-specialist frontline caregivers. This low-cost solution enables early detection of skin cancer, improving patient outcomes by facilitating timely treatment.

Zeit Medical develops a smart headband that continuously monitors brain electrical activity using advanced bioelectronic sensors and AI algorithms to detect neurological injuries such as strokes and seizures. This technology provides immediate alerts for timely medical intervention, enhancing patient safety and improving treatment outcomes for individuals at risk of neurological events.